Michele Schneider | Sep 25, 2022 03:06AM ET
The market has turned for the worst in recent weeks and continues to fall in a bear market fashion.
Most of our portfolio strategies are holding more than 50% cash, some are utilizing inverse ETFs, and in my discretionary trading service, we are largely in cash.
We are looking for profitable opportunities to deploy dry powder.
One of the areas we are watching is the biotech sector, represented above by the IBB or AKA "Big Brother."
The biotech industry is often considered risky since biotech companies, especially in the small/micro-cap sector, are often speculative, and individual stocks can suffer vicious losses.
Yet, many areas of biotech show incredible promise, including regenerative medicine, gene therapy, genomics, new advances in treating cancer and autoimmune disorders, to name just a few.
IBB should be on your shopping list for a few reasons.
We are monitoring the biotech sector for a near-term rebound because of rising worldwide demand for medical advancements, aging populations, and new government backing for research.
h2 ETF Summary/h2S&P 500 (SPY) At least held June lows for what’s it worth. 362 support and 371 resistance
Russell 2000 (IWM) Held June lows 163 support and resistance 170
Dow (DIA) Broke June lows-harbinger? Support at 292 and resistance at 300
Nasdaq (QQQ) Held June lows Support at 269 and resistance at 280
KRE (Regional Banks) Relative outperformer holding the 6-month calendar range high 60 pivotal
SMH (Semiconductors) Held the 6-month calendar range low making 191 pivotal
IYT (Transportation) Trans unhappy-unless Friday’s gap turns out an island bottom.
IBB (Biotechnology) 112 support and 118 resistance
XRT (Retail) Held the 6-month calendar range low Support at 55 and 60 resistance
Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.